Synonym
KP-14; KP14; KP 14
IUPAC/Chemical Name
(E)-N-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)-4-oxo-4-(4-(2',5',6-trichloro-4-methoxy-[1,1'-biphenyl]-3-carbonyl)piperazin-1-yl)but-2-enamide
InChi Key
LPVAFJZSEOPFFT-BUHFOSPRSA-N
InChi Code
InChI=1S/C41H41Cl3N6O8/c1-58-33-23-30(44)27(26-21-24(42)9-10-29(26)43)22-28(33)39(55)49-19-17-48(18-20-49)36(53)14-13-34(51)46-16-5-3-2-4-15-45-31-8-6-7-25-37(31)41(57)50(40(25)56)32-11-12-35(52)47-38(32)54/h6-10,13-14,21-23,32,45H,2-5,11-12,15-20H2,1H3,(H,46,51)(H,47,52,54)/b14-13+
SMILES Code
O=C(CCC1N(C2=O)C(C3=C2C=CC=C3NCCCCCCNC(/C=C/C(N4CCN(C(C5=C(OC)C=C(Cl)C(C6=CC(Cl)=CC=C6Cl)=C5)=O)CC4)=O)=O)=O)NC1=O
Appearance
To be determined
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
852.16
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Pranaw K, Pidlisnyuk V, Trögl J, Malinská H. Bioprospecting of a Novel Plant
Growth-Promoting Bacterium Bacillus Altitudinis KP-14 for Enhancing
Miscanthus × giganteus Growth in Metals Contaminated Soil. Biology
(Basel). 2020 Sep 22;9(9):305. doi: 10.3390/biology9090305. PMID: 32972004;
PMCID: PMC7564662.
2: Makri A, Pissimissis N, Lembessis P, Polychronakos C, Koutsilieris M. The
kisspeptin (KiSS-1)/GPR54 system in cancer biology. Cancer Treat Rev. 2008
Dec;34(8):682-92. doi: 10.1016/j.ctrv.2008.05.007. Epub 2008 Jun 25. PMID:
18583061.
3: Prabhu VV, Sakthivel KM, Guruvayoorappan C. Kisspeptins (KiSS-1): essential
players in suppressing tumor metastasis. Asian Pac J Cancer Prev.
2013;14(11):6215-20. doi: 10.7314/apjcp.2013.14.11.6215. PMID: 24377507.
4: Kirby HR, Maguire JJ, Colledge WH, Davenport AP. International Union of Basic
and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature,
distribution, and function. Pharmacol Rev. 2010 Dec;62(4):565-78. doi:
10.1124/pr.110.002774. PMID: 21079036; PMCID: PMC2993257.
5: Lee CH, Chang CC, Liu JW, Chen RF, Yang KD. Sialic acid involved in
hypermucoviscosity phenotype of Klebsiella pneumoniae and associated with
resistance to neutrophil phagocytosis. Virulence. 2014 Aug 15;5(6):673-9. doi:
10.4161/viru.32076. Epub 2014 Aug 5. PMID: 25098744; PMCID: PMC4139408.
